BNTC
Benitec Biopharma·NASDAQ
--
--(--)
--
--(--)
BNTC fundamentals
During Q2 2026, Benitec Biopharma (BNTC) reported revenue of 0, a YoY change of 0.00%. Net income was -11.84M, a YoY change of -23.92%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
Q4,2017 | Q3,2018 | Q4,2018 | Q1,2020 | Q2,2020 | Q3,2020 | Q4,2020 | Q1,2021 | Q2,2021 | Q3,2021 | Q4,2021 | Q1,2022 | Q2,2022 | Q3,2022 | Q4,2022 | Q1,2023 | Q2,2023 | Q3,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | Q4,2025 | Q1,2026 | Q2,2026 | TTM |
|---|
Start Date | Apr 1, 2017 | Jan 1, 2018 | Apr 1, 2018 | Jul 1, 2019 | Oct 1, 2019 | Jan 1, 2020 | Apr 1, 2020 | Jul 1, 2020 | Oct 1, 2020 | Jan 1, 2021 | Apr 1, 2021 | Jul 1, 2021 | Oct 1, 2021 | Jan 1, 2022 | Apr 1, 2022 | Jul 1, 2022 | Oct 1, 2022 | Jan 1, 2023 | Apr 1, 2023 | Jul 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | Oct 1, 2025 | -- |
End Date | Jun 30, 2017 | Mar 31, 2018 | Jun 30, 2018 | Sep 30, 2019 | Dec 31, 2019 | Mar 31, 2020 | Jun 30, 2020 | Sep 30, 2020 | Dec 31, 2020 | Mar 31, 2021 | Jun 30, 2021 | Sep 30, 2021 | Dec 31, 2021 | Mar 31, 2022 | Jun 30, 2022 | Sep 30, 2022 | Dec 31, 2022 | Mar 31, 2023 | Jun 30, 2023 | Sep 30, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | Jun 30 | -- |
Revenue | 1.09M -- | -- -- | 1.23M +12.65% | 33.00K -- | 77.00K -- | 28.00K -- | -35.00K -- | 55.00K +66.67% | 1.00K -98.70% | 1.00K -96.43% | 2.00K +105.71% | 0 -100.00% | 25.00K +2400.00% | 48.00K +4700.00% | 0 -100.00% | 0 -- | 14.00K -44.00% | 54.00K +12.50% | 7.00K -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- |
Sales and Services Revenue | -150.00K -- | 134.00K -- | -176.00K -17.33% | 33.00K -- | 77.00K -- | 28.00K -- | -35.00K -- | 55.00K +66.67% | 1.00K -98.70% | 1.00K -96.43% | 2.00K +105.71% | 0 -100.00% | 25.00K +2400.00% | 48.00K +4700.00% | 0 -100.00% | 0 -- | 14.00K -44.00% | 54.00K +12.50% | 7.00K -- | 0 -- | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | 0 -- | -- -- |
Other Revenue | 1.24M -- | 1.09M -- | 1.16M -6.29% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Cost of Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gross Profit | -9.75M -- | 1.23M -- | -3.48M +64.32% | 33.00K -- | 77.00K -- | 28.00K -- | -35.00K -- | 55.00K +66.67% | 1.00K -98.70% | 1.00K -96.43% | -57.00K -62.86% | 0 -100.00% | 25.00K +2400.00% | 48.00K +4700.00% | -73.00K -28.07% | 0 -- | 14.00K -44.00% | 54.00K +12.50% | -68.00K +6.85% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Expenses | 3.65M -- | 4.02M -- | 4.22M +15.67% | 1.20M -- | 2.19M -- | 2.14M -- | 2.85M -- | 2.75M +128.94% | 3.26M +48.99% | 3.79M +77.37% | 3.86M +35.24% | 4.82M +75.66% | 4.86M +49.08% | 3.51M -7.54% | 4.74M +22.84% | 4.58M -5.02% | 5.62M +15.72% | 4.39M +25.29% | 4.56M -3.82% | 5.87M +28.25% | 6.93M +23.17% | 4.14M -5.78% | 5.55M +21.75% | 5.79M -1.41% | 10.80M +55.98% | 10.19M +146.03% | 17.18M +209.59% | 9.80M +69.28% | 13.38M +23.80% | 50.54M -- |
Selling, General and Administrative Expenses | 1.31M -- | 4.16M -- | 1.46M +11.13% | 750.00K -- | 1.90M -- | 1.29M -- | 1.90M -- | 1.84M +144.93% | 2.11M +11.40% | 1.03M -20.05% | 1.54M -19.07% | 2.04M +11.16% | 1.71M -18.81% | 1.34M +29.93% | 1.55M +1.11% | 1.92M -5.97% | 1.86M +8.69% | 1.23M -8.15% | 1.37M -11.72% | 1.55M -19.22% | 1.82M -2.09% | 1.58M +28.50% | 2.04M +48.50% | 2.21M +42.23% | 5.42M +197.15% | 4.21M +166.67% | 13.48M +562.13% | 6.43M +191.61% | 7.54M +39.17% | 31.66M -- |
General and Administrative Expenses | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 6.51M -- | -- -- | -- -- | -- -- | 6.65M +2.06% | -- -- | -- -- | -- -- | 6.38M -3.97% | 1.55M -- | 1.82M -- | 1.58M -- | 2.04M -68.10% | 2.21M +42.23% | 5.42M +197.15% | 4.21M +166.67% | 13.48M +562.13% | 6.43M +191.61% | 7.54M +39.17% | 31.66M -- |
Research and Development Expenses | 1.34M -- | 1.95M -- | 1.65M +23.06% | 423.00K -- | 599.00K -- | 805.00K -- | 906.00K -- | 774.00K +82.98% | 1.17M +94.99% | 2.76M +242.61% | 2.44M +169.65% | 2.78M +259.17% | 3.15M +169.35% | 2.17M -21.28% | 3.19M +30.37% | 2.66M -4.32% | 3.76M +19.55% | 3.17M +45.88% | 3.19M +0.03% | 4.43M +66.50% | 5.10M +35.66% | 2.56M -19.07% | 3.51M +10.23% | 3.58M -19.06% | 5.38M +5.55% | 5.98M +133.32% | 3.69M +5.21% | 3.37M -6.00% | 5.83M +8.34% | 18.88M -- |
Loss on Disposal of Assets | 7.00K -- | -- -- | 1.00K -85.71% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Expenses | 992.00K -- | -2.09M -- | 1.11M +12.40% | 26.00K -- | -306.00K -- | 47.00K -- | 48.00K -- | 134.00K +415.38% | -19.00K +93.79% | 7.00K -85.11% | -122.00K -354.17% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -106.00K -- | 1.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Operating Income | -2.56M -- | -2.79M -- | -3.24M -26.41% | -1.17M -- | -2.11M -- | -2.11M -- | -2.89M -- | -2.69M -130.70% | -3.26M -54.38% | -3.79M -79.68% | -3.85M -33.53% | -4.82M -79.26% | -4.83M -48.36% | -3.46M +8.78% | -4.74M -22.91% | -4.58M +5.02% | -5.61M -16.03% | -4.34M -25.46% | -4.55M +3.97% | -5.87M -28.25% | -6.93M -23.48% | -4.14M +4.61% | -5.55M -21.93% | -5.79M +1.41% | -10.80M -55.98% | -10.19M -146.03% | -17.18M -209.59% | -9.80M -69.28% | -13.38M -23.80% | -50.54M -- |
Non-Operating Income (Loss) | -13.00K -- | -- -- | 198.00K +1623.08% | 19.00K -- | 21.00K -- | 9.00K -- | -48.00K -- | -28.00K -247.37% | 7.00K -66.67% | -116.00K -1388.89% | -148.00K -208.33% | -223.00K -696.43% | 14.00K +100.00% | 185.00K +259.48% | -329.00K -122.30% | -513.00K -130.04% | 199.00K +1321.43% | -56.00K -130.27% | -111.00K +66.26% | -80.00K +84.41% | 129.00K -35.18% | -138.00K -146.43% | 828.00K +845.95% | 732.00K +1015.00% | 1.25M +871.32% | 834.00K +704.35% | 1.03M +24.28% | 838.00K +14.48% | 1.54M +22.91% | 4.24M -- |
Gain (Loss) on Other Investment | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 16.00K -- | -- -- | -- -- | -- -- | -11.00K -168.75% | -- -- | -- -- | -- -- | -3.00K +72.73% | -- -- | -- -- | -- -- | -1.00K +66.67% | -- -- | -- -- | -- -- | 0 +100.00% | -- -- | -- -- | -- -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Gain (Loss) on Foreign Currency Exchange | -266.00K -- | -- -- | -44.00K +83.46% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -333.00K -- | -- -- | -- -- | -- -- | -232.00K +30.33% | -- -- | -- -- | -- -- | -415.00K -78.88% | -56.00K -- | 152.00K -- | -118.00K -- | 62.00K +114.94% | 93.00K +266.07% | -294.00K -293.42% | 11.00K +109.32% | 119.00K +91.94% | -89.00K -195.70% | 131.00K +144.56% | 172.00K -- |
Other Non-Operating Income (Loss) | -- -- | -- -- | -- -- | 1.00K -- | 4.00K -- | -7.00K -- | -58.00K -- | -27.00K -2800.00% | 9.00K +125.00% | -114.00K -1528.57% | 170.00K +393.10% | -222.00K -722.22% | 25.00K +177.78% | 195.00K +271.05% | -76.00K -144.71% | -504.00K -127.03% | 208.00K +732.00% | -49.00K -125.13% | 315.00K +514.47% | -18.00K +96.43% | -16.00K -107.69% | -16.00K +67.35% | -153.00K -148.57% | 35.00K +294.44% | 724.00K +4625.00% | 0 +100.00% | -126.00K +17.65% | -84.00K -340.00% | 19.00K -97.38% | -191.00K -- |
Net Interest Expense | -253.00K -- | -- -- | -242.00K +4.35% | -18.00K -- | -17.00K -- | -16.00K -- | -10.00K -- | 1.00K +105.56% | 2.00K +111.76% | 2.00K +112.50% | 1.00K +110.00% | 1.00K -- | 11.00K +450.00% | 10.00K +400.00% | 10.00K +900.00% | 9.00K +800.00% | 9.00K -18.18% | 7.00K -30.00% | 8.00K -20.00% | 6.00K -33.33% | 6.00K -33.33% | 4.00K -42.86% | -920.00K -11600.00% | -604.00K -10166.67% | -823.00K -13816.67% | -823.00K -20675.00% | -1.04M -12.61% | -1.01M -67.38% | -1.39M -68.89% | -4.26M -- |
Interest Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 4.00K -- | -16.00K -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Interest Income | 253.00K -- | -- -- | 242.00K -4.35% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 604.00K -- | -- -- | 823.00K -- | -2.25M -- | 1.01M +67.38% | -- -- | -- -- |
Pretax Income From Continuing Operations | -2.57M -- | -- -- | -3.04M -18.07% | -1.15M -- | -2.09M -- | -2.10M -- | -2.94M -- | -2.72M -136.97% | -3.25M -55.60% | -3.91M -85.97% | -4.00M -36.39% | -5.04M -85.61% | -4.82M -48.25% | -3.27M +16.22% | -5.07M -26.58% | -5.09M -0.95% | -5.41M -12.24% | -4.40M -34.26% | -4.66M +8.01% | -5.95M -16.91% | -6.80M -25.63% | -4.28M +2.68% | -4.72M -1.27% | -5.06M +15.03% | -9.55M -40.51% | -9.35M -118.60% | -16.15M -242.10% | -8.96M -77.21% | -11.84M -23.92% | -46.30M -- |
Income Tax Expense | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Net Income | -2.57M -- | -- -- | -3.04M -18.07% | -1.15M -- | -2.09M -- | -2.10M -- | -2.94M -- | -2.72M -136.97% | -3.25M -55.60% | -3.91M -85.97% | -4.00M -36.39% | -5.04M -85.61% | -4.82M -48.25% | -3.27M +16.22% | -5.07M -26.58% | -5.09M -0.95% | -5.41M -12.24% | -4.40M -34.26% | -4.66M +8.01% | -5.95M -16.91% | -6.80M -25.63% | -4.28M +2.68% | -4.72M -1.27% | -5.06M +15.03% | -9.55M -40.51% | -9.35M -118.60% | -16.15M -242.10% | -8.96M -77.21% | -11.84M -23.92% | -46.30M -- |
Net Income Attributable to Owners of the Company | -2.57M -- | -2.79M -- | -3.04M -18.07% | -1.15M -- | -2.09M -- | -2.10M -- | -2.94M -- | -2.72M -136.97% | -3.25M -55.60% | -3.91M -85.97% | -4.00M -36.39% | -5.04M -85.61% | -4.82M -48.25% | -3.27M +16.22% | -5.07M -26.58% | -5.09M -0.95% | -5.41M -12.24% | -4.40M -34.26% | -4.66M +8.01% | -5.95M -16.91% | -6.80M -25.63% | -4.28M +2.68% | -4.72M -1.27% | -5.06M +15.03% | -9.55M -40.51% | -9.35M -118.60% | -16.15M -242.10% | -8.96M -77.21% | -11.84M -23.92% | -46.30M -- |
Other Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 619.00K -- | 0 -- | 0 -- | 0 -- | -- -- | -- -- | 0 -- | 0 -- | -- -- | -- -- | -- -- |
Net Income Attributable to Common Stockholders | -2.57M -- | -2.79M -- | -3.04M -18.07% | -1.15M -- | -2.09M -- | -2.10M -- | -2.94M -- | -2.72M -136.97% | -3.25M -55.60% | -3.91M -85.97% | -4.00M -36.39% | -5.04M -85.61% | -4.82M -48.25% | -3.27M +16.22% | -5.07M -26.58% | -5.09M -0.95% | -5.41M -12.24% | -4.40M -34.26% | -4.66M +8.01% | -6.57M -29.06% | -6.80M -25.63% | -4.28M +2.68% | -4.72M -1.27% | -5.06M +23.03% | -9.55M -40.51% | -9.35M -118.60% | -16.15M -242.10% | -8.96M -77.21% | -11.84M -23.92% | -46.30M -- |
Other Comprehensive Income | 32.00K -- | -- -- | -44.00K -237.50% | -304.00K -- | 336.00K -- | -901.00K -- | 780.00K -- | 178.00K +158.55% | 208.00K -38.10% | -24.00K +97.34% | 136.00K -82.56% | 239.00K +34.27% | -57.00K -127.40% | -233.00K -870.83% | 261.00K +91.91% | 507.00K +112.13% | -160.00K -180.70% | 45.00K +119.31% | 23.00K -91.19% | 50.00K -90.14% | -172.00K -7.50% | 117.00K +160.00% | -57.00K -347.83% | -101.00K -302.00% | 305.00K +277.33% | -28.00K -123.93% | -123.00K -115.79% | 89.00K +188.12% | -133.00K -143.61% | -195.00K -- |
Total Comprehensive Income | -2.54M -- | -- -- | -3.08M -21.29% | -1.45M -- | -1.75M -- | -3.00M -- | -2.15M -- | -2.54M -75.05% | -3.04M -73.55% | -3.93M -30.97% | -3.87M -79.44% | -4.81M -89.21% | -4.88M -60.25% | -3.51M +10.81% | -4.81M -24.28% | -4.59M +4.58% | -5.57M -14.21% | -4.35M -24.06% | -4.64M +3.50% | -5.90M -28.74% | -6.97M -25.11% | -4.16M +4.37% | -4.78M -3.00% | -5.16M +12.60% | -9.25M -32.67% | -9.38M -125.42% | -16.27M -240.59% | -8.88M -72.02% | -11.97M -29.45% | -46.50M -- |
Total Comprehensive Income Attributable to Owners of the Company | -2.54M -- | -2.83M -- | -3.08M -21.29% | -1.45M -- | -1.75M -- | -3.00M -- | -2.15M -- | -2.54M -75.05% | -3.04M -73.55% | -3.93M -30.97% | -3.87M -79.44% | -4.81M -89.21% | -4.88M -60.25% | -3.51M +10.81% | -4.81M -24.28% | -4.59M +4.58% | -5.57M -14.21% | -4.35M -24.06% | -4.64M +3.50% | -5.90M -28.74% | -6.97M -25.11% | -4.16M +4.37% | -4.78M -3.00% | -5.16M +12.60% | -9.25M -32.67% | -9.38M -125.42% | -16.27M -240.59% | -8.88M -72.02% | -11.97M -29.45% | -46.50M -- |
Basic EPS | 0 -- | -- -- | 0 -- | -1.34 -- | -2 -- | -1.96 -- | -2.65 -- | -2.45 -82.84% | -0.76 +62.00% | -0.82 +58.16% | -0.49 +81.51% | -0.62 +74.69% | -0.59 +22.37% | -0.4 +51.22% | -0.62 -26.53% | -7.98 -1187.10% | -3.34 -466.10% | -2.67 -567.50% | -0.17 +72.58% | -3.05 +61.78% | -2.64 +20.96% | -0.23 +91.39% | -0.47 -176.47% | -0.18 +94.10% | -0.26 +90.15% | -0.24 -4.35% | -0.62 -31.91% | -0.22 -22.22% | -0.26 -- | -1.34 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -3.05 -- | -2.64 -- | -0.23 -- | -- -- | -0.18 +94.10% | -0.26 +90.15% | -0.24 -4.35% | -- -- | -0.22 -22.22% | -0.26 -- | -- -- |
Diluted EPS | -- -- | -- -- | -- -- | -1.34 -- | -2 -- | -1.96 -- | -- -- | -2.45 -82.84% | -0.76 +62.00% | -0.82 +58.16% | -- -- | -0.62 +74.69% | -0.59 +22.37% | -0.4 +51.22% | -- -- | -7.98 -1187.10% | -3.34 -466.10% | -2.67 -567.50% | -- -- | -3.05 +61.78% | -2.64 +20.96% | -0.23 +91.39% | -- -- | -0.18 +94.10% | -0.26 +90.15% | -0.24 -4.35% | -- -- | -0.22 -22.22% | -0.26 -- | -- -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -3.05 -- | -2.64 -- | -0.23 -- | -- -- | -0.18 +94.10% | -0.26 +90.15% | -0.24 -4.35% | -- -- | -0.22 -22.22% | -0.26 -- | -- -- |
You can ask Aime
What is the revenue and EPS growth rate for Benitec Biopharma year over year?What is the market's earnings forecast for Benitec Biopharma next quarter?What were the key takeaways from Benitec Biopharma’s earnings call?What is Benitec Biopharma's latest dividend and current dividend yield?What guidance did Benitec Biopharma's management provide for the next earnings period?Did Benitec Biopharma beat or miss consensus estimates last quarter?What factors drove the changes in Benitec Biopharma's revenue and profit?What were the key takeaways from Benitec Biopharma's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
